University Hospital Schleswig-holstein

This study tests a new radiation approach for men with early-stage prostate cancer. Instead of the usual 5 sessions, it uses only 3 high-dose treatments. The goal is to see if this shorter course causes fewer side effects while still controlling the cancer. About 175 men will tak…

This study tests a special form of vitamin B3 (nicotinamide) that releases in the lower gut to treat mild to moderate ulcerative colitis. About 459 adults will receive either a low or high dose of the vitamin or a placebo. The goal is to see if it can reduce symptoms and improve …

This study compares two treatment approaches for people newly diagnosed with moderate-to-severe ulcerative colitis (UC). One group gets early treatment with mirikizumab, a biologic drug, while the other starts with standard azathioprine pills and can switch to mirikizumab later i…

This study tests whether tralokinumab, an approved eczema drug, can improve moderate-to-severe atopic dermatitis in the genital area. About 30 adults will receive the drug and be monitored for 52 weeks using special skin imaging and symptom questionnaires. The goal is to see if i…

This trial tests a new version of nicotinic acid (vitamin B3) designed to release in the lower gut. It aims to see if it can help people with prediabetes return to normal blood sugar levels and avoid type 2 diabetes. About 390 adults with prediabetes will take either the drug or …

This study is screening 2000 people aged 50 to 99 who do not have Parkinson's disease but may have early risk markers. Researchers will follow participants for five years to track changes in risk markers, motor skills, and non-motor symptoms. The goal is to better understand how …

This study follows 100 women who had preeclampsia, HELLP syndrome, or kidney problems during pregnancy. Researchers will measure blood vessel stiffness and collect health data over time. The goal is to better understand long-term heart and kidney risks and improve future care.

This study looks at why many people with Parkinson's disease crave sugary foods and how those sugars affect their body and symptoms. Researchers will give 50 participants a sugary drink and a placebo drink on different days to measure changes in insulin, blood sugar, and movement…